Ginger cream for gynaecomastia is increasingly promoted online as a natural remedy for male breast tissue enlargement, but does the evidence support these claims? Gynaecomastia — the benign enlargement of glandular breast tissue in males — is a common condition affecting adolescents and older men alike. In the UK, management is guided by NICE CKS, NHS pathways, and the BNF, with established options ranging from watchful waiting to surgery. This article examines what ginger cream is, what it claims to do, whether any clinical evidence supports its use, and what UK men with breast tissue changes should actually do.

What Is Gynaecomastia and How Is It Treated in the UK?

Gynaecomastia is benign male breast glandular enlargement due to oestrogen–androgen imbalance; UK management follows NICE CKS guidance, ranging from watchful waiting and addressing reversible causes to off-label pharmacotherapy or surgery in secondary care.

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males, resulting from an imbalance between oestrogen and androgen activity in breast tissue. It is a relatively common condition, affecting an estimated 30–60% of adolescent boys during puberty, as well as older men in whom testosterone levels naturally decline. In many cases, the condition resolves without intervention, particularly in adolescents.

In the UK, the initial assessment of gynaecomastia typically takes place in primary care. A GP will take a thorough history and perform a clinical examination to distinguish true gynaecomastia (glandular tissue) from pseudogynecomastia (fatty tissue), and to rule out underlying causes such as:

• Hormonal disorders (e.g., hypogonadism, hyperthyroidism)

• Liver or kidney disease

• Medication side effects — a wide range of medicines can contribute, including spironolactone, anabolic steroids, some antipsychotics, finasteride, antiandrogens, cimetidine, ketoconazole, digoxin, and certain antiretrovirals; cannabis use has also been associated with gynaecomastia

• Testicular tumours, which, although rare, require prompt exclusion

Where an underlying cause is identified, treating that cause — including reviewing and substituting causative medicines where clinically appropriate — is the primary management strategy. For persistent or symptomatic gynaecomastia, referral to an endocrinologist or breast surgeon may be appropriate.

Surgical options, including subcutaneous mastectomy or liposuction, are available on the NHS in specific clinical circumstances, though access varies by Integrated Care Board (ICB). Pharmacological treatments such as tamoxifen or raloxifene are sometimes used off-label in secondary care for recent-onset, painful gynaecomastia; these are specialist options and are not for routine use in primary care. There is no dedicated NICE guideline for gynaecomastia; management in UK practice is guided by NICE CKS: Gynaecomastia, NHS pathways, and the BNF.

When to seek urgent referral: Any male with breast changes that raise concern for malignancy — such as a hard, irregular, or rapidly enlarging unilateral mass, nipple retraction or discharge, skin changes (e.g., peau d'orange), or palpable axillary lymph nodes — should be referred urgently under the NICE NG12 two-week-wait pathway for suspected breast cancer. A testicular mass or associated symptoms should prompt urgent urology referral under the same pathway.

What Is Ginger Cream and What Does It Claim to Do?

Ginger cream is an unlicensed topical preparation marketed online for reducing male breast tissue, but the MHRA has not approved it for this purpose and no credible biological mechanism supports its use.

Ginger cream is a topical preparation containing extracts derived from Zingiber officinale, the common ginger plant. It is widely available online and in health food shops, often marketed for purposes ranging from pain relief and improved circulation to, more recently, the reduction of localised fat deposits and breast tissue in men. Proponents of ginger cream for gynaecomastia claim that the active compounds in ginger — primarily gingerols and shogaols — may influence hormone metabolism or reduce localised adipose and glandular tissue when applied directly to the chest.

These claims are largely driven by social media content, online forums, and unregulated supplement marketing rather than clinical evidence. The Medicines and Healthcare products Regulatory Agency (MHRA) has not approved any ginger-based topical cream as a treatment for gynaecomastia. Under MHRA guidance on borderline products, any product that makes a medicinal claim — such as treating or reducing breast tissue — requires a UK marketing authorisation to be sold legally as a medicine. Products making such claims without appropriate licensing may not meet the safety and efficacy standards required of regulated medicines in the UK.

From a pharmacological standpoint, there is no established mechanism by which topically applied ginger extract could selectively reduce glandular breast tissue. While ginger possesses some anti-inflammatory and antioxidant properties when consumed orally, the clinical evidence for meaningful transdermal absorption of its active compounds is lacking, and there is no credible biological pathway linking topical ginger application to hormonal modulation or glandular tissue regression. Consumers should approach such products with caution and scepticism, particularly when they are promoted as alternatives to evidence-based medical care.

Is There Any Clinical Evidence for Ginger Cream in Gynaecomastia?

There is no robust clinical evidence — from RCTs, systematic reviews, or peer-reviewed studies — supporting topical ginger cream as a treatment for gynaecomastia; existing ginger research involves oral ingestion in unrelated contexts.

To date, there is no robust clinical evidence — from randomised controlled trials, systematic reviews, or peer-reviewed studies — supporting the use of ginger cream as a treatment for gynaecomastia. Searches of established clinical databases, including the Cochrane Library, NICE Evidence, and PubMed, yield no relevant studies evaluating topical ginger preparations for this indication.

Some laboratory-based (in vitro) and animal studies have explored ginger's potential effects on hormone levels, particularly its possible influence on testosterone and oestrogen metabolism when taken orally. A small number of studies have suggested that oral ginger supplementation may modestly increase testosterone levels in certain populations, such as infertile men. However, these findings:

• Are based on oral ingestion, not topical application

• Involve small sample sizes and lack rigorous methodology

• Have not been replicated in large, well-designed human trials

• Have not been studied in the context of gynaecomastia specifically

Extrapolating these preliminary findings to support the use of a topical ginger cream for breast tissue reduction in men is not scientifically justified. Patients who have encountered claims to the contrary — particularly on social media platforms or commercial websites — should be aware that such content is not peer-reviewed and may be misleading. Relying on unproven remedies may delay appropriate diagnosis and treatment of an underlying condition.

Safety Considerations and Potential Skin Reactions

Topical ginger preparations can cause contact dermatitis, skin irritation, and allergic reactions; many products sold online are manufactured outside the UK and may not meet MHRA quality standards.

Although ginger is generally regarded as safe when consumed as a food or dietary supplement, topical application of ginger-based products carries its own set of considerations. The skin of the chest, like other areas of the body, can react adversely to concentrated plant extracts, particularly when applied repeatedly or in high concentrations.

Potential adverse effects associated with topical ginger preparations include:

Experiencing these side effects? Our pharmacists can help you navigate them →

• Contact dermatitis — an inflammatory skin reaction characterised by redness, itching, and blistering

• Skin irritation or burning sensation, particularly in individuals with sensitive skin

• Allergic reactions, which may range from mild localised redness to more significant hypersensitivity responses

Individuals with known allergies to plants in the Zingiberaceae family (which includes turmeric and cardamom) should exercise particular caution. Ginger cream should not be applied to broken, inflamed, or irritated skin. If any signs of irritation, rash, or allergic reaction develop, the product should be discontinued immediately and advice sought from a pharmacist or GP. Signs of a severe allergic reaction — such as widespread hives, facial swelling, or difficulty breathing — require urgent medical attention (call 999 or go to A&E).

It is also worth noting that many ginger creams sold online are manufactured outside the UK and may not be subject to the same quality controls as MHRA-regulated products or those compliant with UK Cosmetics Regulation. These products may contain additional ingredients — such as preservatives, fragrances, or other botanical extracts — that carry their own risk of skin reactions, and imported products purchased online may bypass UK regulatory oversight.

From a patient safety perspective, it is advisable to perform a patch test before applying any new topical product to a larger area of skin. Suspected adverse reactions to any medicine or herbal product can be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk). Importantly, no topical product should be used as a substitute for professional medical evaluation of breast tissue changes.

Evidence-Based Management of Gynaecomastia in UK Practice

UK management follows a stepwise approach guided by NICE CKS, including watchful waiting for adolescents, addressing causative medicines, off-label SERMs in secondary care, and surgical referral for persistent or distressing cases.

There is no dedicated NICE clinical guideline specifically for gynaecomastia; however, management is guided by NICE CKS: Gynaecomastia, NHS pathways, and the BNF. The general approach within UK clinical practice follows a stepwise model based on the underlying cause, duration, and severity of the condition.

Key principles of evidence-based management include:

• Watchful waiting is appropriate for physiological gynaecomastia in adolescents, as the majority of cases resolve spontaneously within one to two years

• Addressing reversible causes — such as stopping or substituting causative medications — is a priority where applicable

• Pharmacological treatment with selective oestrogen receptor modulators (SERMs) such as tamoxifen may be considered in secondary care for persistent, painful, or psychologically distressing gynaecomastia; these are used off-label (as noted in the BNF), are most likely to be effective when used early in the course of the condition (within the first 6–12 months, before fibrotic changes occur), and are not for routine use in primary care

• Aromatase inhibitors are generally not recommended for gynaecomastia due to limited evidence of benefit and their adverse effect profile

• Surgical referral may be appropriate for longstanding gynaecomastia (typically beyond two years), where fibrotic changes make spontaneous resolution unlikely, or where the condition causes significant psychological distress

NHS surgical treatment is subject to local ICB commissioning policies, and access may be restricted in some regions unless specific clinical criteria are met. Patients seeking treatment should be referred through their GP to an appropriate specialist — either an endocrinologist, breast surgeon, or plastic surgeon depending on the clinical picture. No over-the-counter topical product, including ginger cream, features in any evidence-based pathway for the management of gynaecomastia.

When to Speak to a GP About Breast Tissue Changes

Any new breast lump, rapid enlargement, nipple discharge, or skin changes in a male should prompt prompt GP assessment; features suspicious for malignancy warrant urgent two-week-wait referral under NICE NG12.

Any new or unexplained change in breast tissue in a male patient warrants prompt medical assessment. While gynaecomastia is most commonly benign, it is essential to exclude serious underlying conditions, including testicular cancer and, rarely, male breast cancer — the latter accounting for approximately 1% of all breast cancer diagnoses in the UK, according to Cancer Research UK.

Contact your GP promptly if you notice:

• A new lump or swelling in one or both breasts

• Breast tissue that is tender, painful, or rapidly enlarging

• Nipple discharge, skin changes (such as peau d'orange), or nipple inversion

• Asymmetrical breast enlargement, particularly if only one side is affected

• Associated symptoms such as unexplained weight loss, fatigue, or testicular changes

A hard, irregular, or rapidly enlarging unilateral breast mass, nipple retraction, skin tethering, or palpable axillary lymph nodes should be assessed urgently. Under NICE NG12 (Suspected Cancer: Recognition and Referral), such features may warrant a two-week-wait referral for suspected breast cancer. A testicular mass should prompt urgent urology referral under the same pathway.

It is particularly important not to delay seeking medical advice by attempting to self-treat with unproven remedies such as ginger cream. A GP can arrange appropriate investigations, which may include:

• Blood tests: LH, FSH, testosterone, oestradiol, prolactin, hCG, thyroid function, and liver and renal function

• Imaging: testicular ultrasound where a testicular mass is suspected; breast ultrasound or mammography if suspicious clinical features are present

For patients who feel embarrassed or uncertain about discussing breast changes, it may be reassuring to know that GPs are experienced in assessing this condition and that early assessment leads to better outcomes. The NHS 111 service can also provide initial guidance if access to a GP is not immediately available. Evidence-based medical care — rather than unregulated topical products — remains the safest and most effective approach to managing gynaecomastia.

Frequently Asked Questions